Renal papillary necrosis medical therapy

Jump to navigation Jump to search

Renal papillary necrosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Renal papillary necrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Renal papillary necrosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal papillary necrosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal papillary necrosis medical therapy

CDC on Renal papillary necrosis medical therapy

Renal papillary necrosis medical therapy in the news

Blogs on Renal papillary necrosis medical therapy

Directions to Hospitals Treating Renal papillary necrosis

Risk calculators and risk factors for Renal papillary necrosis medical therapy

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

Overview

The mainstay of therapy in renal papillary necrosis is supportive care and treating the underlying cause such as discontinuation of analgesics. In severe cases, dialysis or renal replacement therapy may be required.

Medical therapy


References

  1. Lindvall N (1978). "Radiological changes of renal papillary necrosis". Kidney Int. 13 (1): 93–106. doi:10.1038/ki.1978.12. PMID 713272.
  2. "Renal papillary necrosis: MedlinePlus Medical Encyclopedia".